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Introduction 
Synovial joint surface defects are important causes of Osteoarthritis (OA), the most 
prevalent disease of synovial joints, afflicting humans and animals and causing a huge 
healthcare, welfare and economic burden (Cross, et al. 2014).  A considerable amount of 
research time and effort is directed at devising tissue engineering strategies to enhance 
joint surface defect healing, including using cell based therapies, tissue engineering 
solutions and small molecule treatment.  However the development of optimal repair 
strategies is hampered by a lack of full understanding of the underlying mechanisms by 
which joint surface defects heal.  Whilst a number of studies exist in rodents and small 
animals, relatively little is known of the healing mechanism of osteochondral defects in 
large animals and, by inference, in man. 
 
Joint surface defects occur either in the cartilage (‘chondral’ defects) or develop in the 
cartilage and underlying bone (‘osteochondral’ defects).  Osteochondral defects have 
healing capacity if they are small and are believed to heal by recruiting non-differentiated 
bone marrow-derived stromal/stem cells contained in the bone marrow into the damaged 
site.  In contrast, chondral defects have a poor intrinsic healing capacity. Treatment 
strategies to heal chondral defects often utilise the bone marrow-derived stromal/stem 
cell population by accessing the bone marrow through microfracture techniques, which 
provide cost-effective and functional healing in many cases (de Mulder, et al. 2014,van 
Susante, et al. 2003,MIller, et al. 2015). The precise contribution of the stromal stem cell 
population to the healing of osteochondral defects, however, is not known, although they 
may have both a direct and/or indirect (modulatory) effect on the repair tissue. 
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The mechanism by which osteochondral defects heal has been described in a 
number of animals, with most work being performed in rabbits.  Shapiro et al 
(1993) described the sequence of healing in 3mm diameter osteochondral defects of 
the femoral trochlea including an initial fibrin repair, mesechymal cell recruitment, 
cartilage formation starting adjacent to the damaged cartilage and subsequent bone 
formation.  Other work, in larger animals, has described cartilage formation 
adjacent to the residual damaged cartilage an.  It has been shown that a number of 
different parameters can affect both the efficiency of healing and possibly the 
mechanism of healing, including the position of the defect in the knee joint (with 
both anatomical considerations (Jung, et al. 2009,Orth, et al. 2013) and 
biomechanical differences (Duda, et al. 2005) being important), the size and depth 
of the defect (Nosewicz, et al. 2012) and the age of the animal (Bos, et al. 2006). 
 
The sheep is a commonly used translational model for evaluating efficacy of potential 
treatments for osteochondral defects (Orth, Meyer, Goebel, Eldracher, Ong, Cucchiarini 
and Madry 2013,Getgood, et al. 2012,Novak, et al. 2016), however the mechanisms by 
which osteochondral defects heal in sheep are not described.  The aim of this study was 
to describe the temporal sequence of healing of 7mm diameter osteochondral defects of 
the distal femur in the sheep in order to provide key information on those processes that 
are potential targets for therapy.  
 
 
Materials and Methods 
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This study received approval from both the Animal Welfare and Ethical Review Board, 
Cambridge University  and the UK Home Office (Project Licence number 70/8165) .   
 
Animals:  Forty skeletally mature female Welsh Mountain Sheep (mean age 3.2 +\- 0.8 
years) were included in the study, representing the control (untreated empty defect) 
animals from two experiments conducted in our laboratory performed by the same 
surgical team.  The experiments were conducted 12 months apart in three cohorts, with 
the surgical component of the work carried out in the same calendar month each year.  
The feed, husbandry and location of the sheep was the same in all animals. The animals 
were all obtained from the same supplier source. 
 
Animal anaesthesia, preparation and surgical technique: General anaesthesia was 
induced with an injection of thiopentone (3mg/kg) and maintenance achieved via 
inhalational anaesthetic of a mixture of isofluorane, nitrous oxide and oxygen.  
Perioperative analgesia was provided by pre-operative intramuscular carprofen. 
Antibiotic prophylaxis was given via intramuscular procaine penicillin.  The basic 
surgical procedure was identical for all subjects and performed under strict asepsis.  Each 
stifle was physically examined for any abnormalities whilst anaesthetised.  If any gross 
instability or pathology was found, the animal was excluded from participation within the 
study.  
The animal was placed in a dorsal recumbency position and, following surgical 
preparation, the left stifle joint opened via a parapatellar approach.  Following patella 
subluxation, a full thickness 7mm diameter x 6mm deep osteochondral defect was created 
b) a) 
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in the medial femoral condyle (MFC) using a hand drill.  The joint was closed in a 
standard fashion.  No splints, casts or immobilisation techniques were used in any animal.  
Postoperatively, animals were allowed to fully weight bear, but kept in small pens for 48 
hours to reduce ambulation.  All animals were housed indoors for the remaining study 
period in large pens or outdoor in fields, both of which permitted normal ambulation.  
Animals were killed with an overdose of injectable anaesthetic at 1, 2, 4 , 8, 12, 18 and 
26 weeks post surgery. 
 
Histology: Specimens were decalcified in formic acid/sodium citrate over four weeks.  
Following complete decalcification, the specimens were dehydrated through a series of 
ethanol exchanges of increasing concentrations, cleared in xylene and then embedded in 
paraffin wax.  Sections of 8 m thickness were made through the central portion of the 
defect.  Sections were stained with Toluidine Blue and/or Safranin O/Fast Green.  A 
semi-quantitative histological analysis was performed as described by Manil-Varlet 
(Mainil-Varlet, et al. 2003), based on a semi-quantitative scoring system originally 
described by O’Driscoll (O'Driscoll, et al. 1988)(Table 1) . This scoring system has a 
maximum of 34 points and is suitable for demonstrating longitudinal healing of 
osteochondral defects in large animal species (Jung, Breusch, Daecke and Gotterbarm 
2009).  Scoring was carried out blindly by one observer (FH). 
 
Immunohistochemistry:   Immunohistochemistry was performed as described previously 
(Getgood, Henson, Skelton, Herrera, Brooks, Fortier and Rushton 2012) The following 
primary antibodies were used in this study; polyclonal rabbit anti type X collagen  
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(ab58632, Abcam, UK, 1 in 200 dilution) and monoclonal mouse anti-PCNA (DAKO, 
UK). Type X collagen immunostaining was detected with a FITC-conjugated secondary 
anti-rabbit secondary antibody (Sigma) and PCNA immunostaining was detected with a 
TRITC-conjugated secondary anti-mouse antibody (Sigma).  Normal species-specific 
serum was used as a control for each antibody. 
 
  
Results 
Weeks 1-2: The osteochondral defect is infilled with fibrous tissue 
At week one and two after injury the defect site had filled with blood clot and fibrous 
tissue.  The fibrous tissue was organised with a visible surface layer. At the edge of the 
damaged articular cartilage there was a loss of normal architecture (Figure 1A).  The 
normal chondrocyte arrangement was replaced with a zone of multicellular chondrocyte 
‘clusters’ associated with a zone of proteoglycan loss as detected by a reduction in 
toluidine Blue staining at the site.   
 
Weeks 4-8: Chondrocytes form adjacent to the edge of damaged cartilage and bone 
formation occurs through endochondral ossification. 
Between weeks four and eight neo-cartilage was evident at the top edges of the defect 
immediately adjacent to the edge of the remaining cartilage and the cartilage clusters 
(Figures 1B and 2). The cells within the chondrocyte clusters were positively stained for 
PCNA immunoreactivity indicating active cycling.  Close examination of the tissue 
suggested that these new chondrocytes derived primarily from differentiation of the 
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fibrous tissue clot adjacent to the damaged cartilage.  However, there was some 
suggestion that chondrocytes at the edges of the damaged cartilage were contributing to 
repair as the orientation of the chondrocytes at the edges of the damaged cartilage was 
towards the neocartilage rather than the articular surface (Figure 2).  
 
From week 4 onwards  the area in which chondrocytes were seen was now extending 
towards the base of the defect following the edge of the bone.  In defects of increasing 
age the chondrocytes reached deeper towards the base of the lesion until they joined with 
the chondrocytes arising from the opposite side of the lesion by approximately 8 weeks 
post-injury, effectively lining the exposed bone edges of the defect (Figure 3).  
Chondrocytes adjacent to the exposed bone edge were observed to be larger and more 
rounded than the new chondrocytes that were arising towards the top of the defect with a 
morphology similar to hypertrophic chondrocytes.  Positive type X collagen staining in 
these larger chondrocytes confirmed their identity as hypertrophic chondrocytes (Figure 
3).  No evidence of intramembranous ossification was detected in any of the sections 
studied, nor were any cartilage ‘islands’ observed within the fibrous tissue away from the 
damaged bone edges. 
 
Week 8 to 12: Bone formation occurs through endochondral ossification from the base 
and edges of the lesion. 
From week 8 onwards, the healing process continued via a process of endochondral 
ossification with a gradual increase in the amount of cartilage within the defect (Figure 
4).  The cartilage formed within the healing tissue did not show any recognisable 
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columnar structure at 8w but, by 12w, the chondrocytes were beginning to become more 
structured at the edge of the lesion close to the intact cartilage. 
 
Week 18 New bone formation continues and cartilage is removed 
At week 18 new bone had been formed at the edges and base of the defect: at this time 
point a characteristic ‘v’ shaped healing lesion was observed (Figure 4). There was 
evidence of tidemark reformation in the newly formed cartilage only at the edges of the 
defect and the chondrocytes within this newly formed cartilage had organised into an 
approximately columnar structure. 
 
Week 26 Healing is nearly complete 
Healing was very close to completed at 26 weeks (mean histological score 29.6/34).  At 
26 weeks the defect had been filled in with cartilage and bone.  The cartilage/bone 
junction was positioned at the correct anatomical site within the cartilage/bone unit, 
however the tidemark was not completely reformed in any animal.  Within the 
subchondral bone underneath the newly formed cartilage there were numerous cartilage 
remnants remaining which would require further resorption and remodelling in future. No 
evidence of osseous hypertrophy was found in any sample studied.  
 
Semi-Quantitative analysis 
A scoring system suitable for scoring the healing of experimental large animal 
osteochondral defects was used.  This scoring system demonstrated that an increase in 
score correlated with the age of the lesion in these medial femoral condyle lesions (Figure 
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5).  At 1, 2 and 4 weeks of healing the mean healing score (out of a possible total of 34) 
was 7.6 +/- 0.94, 7.3 +/-1.3 and 8.6 +/- 1.7 respectively, with the majority of the scoring 
coming from the integration of the infill material with the intact cartilage edges and the 
underlying bone. At 8w of healing the mean score had risen to a mean of 14.6 +/-1.7, 
increasing through a mean of 16.3 +/-2.5 at 12w, a mean of 25+/-0 at 18w and ending at 
26w with a mean of 29.6 +/-0.63.  Between 4w and 8w there was increased scoring for 
tissue infill and surface integrity and then increasing scoring for morphology, structure 
and matrix staining in the later time points.  The tidemark was not full restored at 26w in 
any animal. 
 
Discussion 
Healing of joint surface defects remains a clinical challenge with significant research 
endeavour directed at optimising treatment strategies.  Understanding the 
mechanisms behind normal healing is vital to inform therapy selection and 
experimental design.  In this study we examined the temporal sequence of healing 
within an osteochondral defect experimentally created in the medial femoral 
condyle in the sheep and demonstrated that healing of the defect occurs via 
endochondral ossification.   The defect size in this study was 7mm diameter, which 
was nearly fully healed within 26 weeks at this anatomical site (cartilage formed in 
the appropriate place but with some remodelling of subchondral bone and tidemark 
formation still occurring).  This data indicates that a 7mm osteochondral defect in 
the medial femoral condyle is able to achieve spontaneous repair and is thus 
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considered as below a ‘critical size’ i.e. a defect of a size that cannot spontaneously 
heal (Rudert 2002).   
Whether or not an experimental defect is small enough to achieve spontaneous 
repair is extremely important in the evaluation of therapeutic interventions.  
Various factors play a role in determining whether a defect can spontaneously 
repair, including  the anatomical site of the lesion in the joint (medial femoral 
condyle lesions are reported to heal more poorly than comparable lesions in the 
trochlea in the sheep (Orth, Meyer, Goebel, Eldracher, Ong, Cucchiarini and Madry 
2013) but better in the mini-pig (Jung, Breusch, Daecke and Gotterbarm 2009).  In 
the goat, it has been reported that a 6mm diameter defect in the medial femoral 
condyle does not undergo spontaneous repair (Jackson, et al. 2001), however, in 
other studies in sheep an 8.3mm diameter osteochondral defect in the medial 
femoral condyle did not heal after 6m (Nosewicz, Reilingh, van Dijk, Duda and Schell 
2012),  suggesting that a defect of approximately 8mm is the size below which 
spontaneous healing occurs in the medial femoral condyle of adult sheep at 6m.  
 
These results show that ovine osteochondral healing occurs through a defined 
sequence of events.  Initially the lesion is filled with a haematoma that then rapidly 
remodels to form a fibrous clot.  The first sign of organ-specific tissue is the 
formation of neocartilage adjacent to the damaged edges of the cartilage. At this 
stage in the healing process, there was a very similar appearance to the healing 
defects in different animals at the same time post surgery. This neo-cartilage is then 
observed, over time, to stream down the edges of the defect supported by the 
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underlying bone, coalescing at the base of the lesion.  New bone is produced 
circumferentially on the edges and base of the lesion via the process of 
endochondral ossification, as evidenced by the characteristic hypertrophic 
morphology of the chondrocytes and the expression of type X collagen.  In this sheep 
osteochondral repair process, no evidence of MSC cell condensation was detected in 
the centre of the lesion as had been reported in the rabbit (Shapiro, et al. 1993). As 
healing progresses, particularly at weeks 8 and 12, there was a wider difference 
between individual animals with, at 12w the ICRS scoring varying between 13 and 
19, primarily due to differences in the maturation state of the new cartilage formed, 
however, by 18w and then at 26w there was a marked reduction in variability, with 
all animals having a similar appearance.  These results indicate that, at 26w post 
surgery animals have a similar histological appearance in 7mm defects in the medial 
femoral condyle. 
 
The origin of the neocartilage and the cartilage that then covers the exposed bone 
surface is not known.  The neocartilage originates at the junction between the 
fibrous clot and the damaged cartilage and could arise either from a) the damaged 
cartilage edge (via activation of cartilage progenitor cells (Nelson, et al. 2014)) or by 
b) recruitment and differentiation of MSC (released from the bone marrow).  PCNA 
labelling indicated that the cells within the fibrous clot and the chondrocyte clusters 
in the damaged cartilage edge are actively cycling.  Shapiro et al (Shapiro, Koide and 
Glimcher 1993) showed, using longitudinal tritiated thymidine labelling, that there 
was significant labelling of undifferentiated cells within the fibrous clot, as well as in 
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the damaged cartilage, and concluded that the undifferentiated cells primarily 
contributed to the regeneration of the defect. However, some histological sections in 
this study do appear to show a possible contribution of damaged cartilage to new 
cartilage production and further studies are required to investigate the precise 
contribution of the chondrocytes and undifferentiated cells in large animal 
osteochondral healing. 
 
Whatever proves to be the source of the neocartilage, this study demonstrates the 
importance of the damaged tissue in directing healing.  Neocartilage is initially 
formed adjacent to the damaged cartilage, indicating that, if not directly 
contributing to the neocartilage production,  the damaged cartilage is providing an 
appropriate structural support for neocartilage production and/or secreting local 
trophic factors to induce differentiation of undifferentiated cells into cartilage.  It is 
known that adult articular cartilage is a rich source of morphogenic signals upon 
injury (Dell'Accio, et al. 2006)  (Watt, et al. 2013,Burleigh, et al. 2012) and cartilage 
damage induces activation of factors including bone morphogeneic proteins (BMP) 
and Wnt  signalling proteins within damaged cartilage ((Dell'Accio, et al. 
2006,Dell'Accio, et al. 2008), (Dell'Accio, De Bari, El Tail, Barone, Mitsiadis, O'Dowd 
and Pitzalis 2006),  and released into the local environment, for example fibroblastic 
growth factors (FGF) (Chong, et al. 2013). 
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The importance of the damaged tissue in directing repair is also apparent in the 
progression of cartilage formation as it lines the edge of the damaged bone prior to 
infilling the defect.  This observation that endochondral ossification occurs upon the 
damaged bone is unlike the situation during fracture repair, where the cartilage 
callus is laid down through endochondral ossification on the intact periosteal bone 
surface rather than on the fractured bone ends (Ford, et al. 2004), demonstrating 
that osteochondral repair, in these animals at this anatomical site, occurs in a 
dissimilar repair environment to that which occurs in fracture repair. 
 
As previously discussed regarding the role of damaged cartilage in neocartilage 
formation, whether the bone is acting as a physical support and/or as a producer of 
trophic mediators for chondrogenesis is not known. Differentiation of MSC into 
chondrocytes is enhanced by increased load (Angele, et al. 2003,Terraciano, et al. 
2007): we could hypothesise that the junction between  fibrous tissue and bone 
experiences increased load relative to elsewhere in the fibrous tissue within the 
defect and that the MSC in this area are being influenced by this load differential.    
The repair tissue/bone interface also represents an area of altered vascularity and 
oxygen tension within the damaged tissue and it has been demonstrated, by many 
authors that these vaiables, among many others, can affect cartilage repair proceses  
(Babarina, et al. 2011) (Shang, et al. 2014,Gaut and Sugaya 2015). Clearly, further 
studies are required to fully characterise the role of bone in osteochondral repair. 
 
  16 
There have been few studies that describe longitudinal observations of healing in 
large animal models and, to the authors’ knowledge, there have been no previous 
studies of longitudinal healing in the medial femoral condyle of the sheep. Jackson et 
al (Jackson, Lalor, Aberman and Simon 2001) demonstrated, over 52 weeks in a goat 
model, that a 6mm diameter osteochondral defect fails to heal and that progressive, 
resorption of the defect and subsequent collapse of the defect occur.  As observed in 
this study, clustering of chondrocytes at the edges of the damaged cartilage was 
noted but endochondral ossification (as determined by toluidine blue staining) was 
only detected at the base of the lesion.   Gotterbarn et al (Gotterbarn, et al. 2008) 
reported that during healing of the medial aspect of the lateral trochlea ridge in 
mini-pigs endochondral ossification and cartilage streaming was observed at the 
upper edges of the lesion only.   
 
The results of this study show that endochondral ossification is the mechanism by 
which osteochondral defects heal in the sheep.  The quantitative analysis of the 
healing shows that there is little variability in the initial stages of healing between 
animals, but that variability is more marked between 8 and 12w of repair.  However, 
by the end point of this study, 26w the variability was reduced and the appearance 
of the healing defects similar.   In sheep, unlike in laboratory animals such as mice, 
there are far more genetic differences between individuals.  In this study we have 
sought to eliminate individual differences as much as is practically possible, using 
female sheep of a similar age of the same breed from the same supplier, however, 
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these studies were conducted over a 3 year period (drawn from the control animals 
of different studies) and the results may be confounded by individual variations.  
 
This finding provides information that may assist the design of tissue engineering 
strategies to heal osteochondral defects.  However, this finding also poses a 
potential dilemma for strategies that have been used to reduce the deleterious 
osseous overgrowth that can occur during joint surface defect repair (Blanke, et al. 
2009,Klinger, et al. 2011).  On the basis of the findings reported here, future 
regenerative therapies should be directed at maintaining chondrocyte phenotype in 
the chondral layer of the defect once the subchondral bone plate is restored and 
strategies to inhibit endochondral ossification should be used cautiously. 
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